Skip to Main Content

Cancer Outcome Reporting for the Avera Cancer Institute

When deciding where to receive your cancer treatment, you want a program that is nationally accredited and even exceeds the average national outcomes in cancer care. The Avera Cancer Institute offers that program. We have published our outcomes in cancer care for your review.

Breast Cancer Outcomes

Breast Multi-Agent Chemotherapy 2012

Combination chemotherapy is considered or administered within four months (120 days) of diagnosis for women under 70 with AJCC T1cNOMO, or stage II or III hormone receptor negative breast cancer.

Breast Conserving Surgery with Radiation Therapy 2011

Radiation therapy is administered within one year (365 days) of diagnosis to women under age 70 receiving breast conserving surgery for breast cancer.

Breast HT/AI 2011

Tamoxifen, or third generation aromatase inhibitor, is considered or administered within one year (365 days) of diagnosis for women with AJCC T1cNOMO, or stage II or III hormone receptor positive breast cancer.

Colon/Rectal Cancer Outcomes

Rectum Cancer with Adjuvant Radiation Therapy 2012

Radiation therapy is considered or administered within six months (180 days) of diagnosis for patients under the age of 80 with clinical or pathologic AJCC T4NOMO or stage III receiving surgical resection for rectal cancer.

Colon with at Least 12 Regional Lymph Nodes 2012

At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer.

Colon with Adjuvant Chemotherapy 2012

Adjuvant chemotherapy is considered or administered within four months (120 days) of diagnosis for patients under the age of 80 with AJCC stage III (lymph node positive) colon cancer.

The Rapid Quality Reporting System (RQRS) promotes and facilitates evidence-based care for patients at Commission on Cancer-accredited programs by actively monitoring and assessing with compliance to four National Quality Forum-endorsed measures and two surveillance measures of cancer care for breast and colorectal cancer patients in real clinical time.*

*Source: facs.org/cancer/ncdb/rqrs.html